TY  - GEN
AU  - Williams, Laura
AU  - Jurado, Silvia
AU  - Llorente, Francisco
AU  - Romualdo, Alberto
AU  - González, Sara
AU  - Saconne, Ana
AU  - Bronchalo, Isabel
AU  - Martínez-Cortes, Mercedes
AU  - Perez-Gomez, Beatriz
AU  - Ponz, Fernando
AU  - Jiménez-Clavero, Miguel Ángel
AU  - Lunello, Pablo
PY  - 2021
DO  - 10.3389/fpls.2021.699665
SN  - 1664-462X
UR  - http://hdl.handle.net/20.500.12105/14163
AB  - Background: The fight against the current coronavirus disease 2019 (COVID-19) pandemic has created a huge demand of biotechnological, pharmaceutical, research and sanitary materials at unprecedented scales. One of the most urgent demands affects the...
LA  - eng
PB  - Frontiers Media
KW  - COVID-19
KW  - ELISA coronavirus
KW  - SARS CoV-2 nucleocapsid protein
KW  - Biofactories
KW  - Molecular farming
KW  - Plant expression
TI  - The C-Terminal Half of SARS-CoV-2 Nucleocapsid Protein, Industrially Produced in Plants, Is Valid as Antigen in COVID-19 Serological Tests
TY  - research article
ER  -